News
14d
Stockhead on MSNDr Boreham’s Crucible: Can this biotech emerge from Mesoblast’s shadow and ride ‘stem cells 2.0’?Investors now have three ASX-listed stem cell therapy companies to choose from – and we can thank Mesoblast for inspiring the third.
Newsweek on MSN12d
Mom Defends Decision To Take Her Daughter For Illegal Medical ProcedureStem cell therapy is crucial for Lydia, diagnosed with cerebral palsy due to a loss of brain matter that cannot regenerate.
Shares of gene therapy specialist, CRISPR Therapeutics (NASDAQ: CRSP) have been beaten down a long way despite some ...
Explore the evolving landscape of cell and gene therapies (CGTs) in gastroenterology. Key therapies include Anterogen's Cupistem and Takeda's Alofisel, the latter recently withdrawn by EMA. Understand ...
But whether or not they realize it, many thousands of clones have already been produced as the cloning process has become ...
A bit of shedding every day is part of a normal hair cycle, but if you start to see an increase in the amount of hair caught ...
So is it time to add viruses to one's microbiome-feeding regimen of probiotics and prebiotics, synbiotics (which combine the ...
Omeros faces critical liquidity challenges, with limited cash runway and rising dilution risks. Its cash runway is ...
They had grown up together, the boy and his horse. Their bond was innate. In fact, he has been told that his mother was on horseback when her waters broke. That was how it was, up in the mountains.
Thanks to generous support and partnership from Alexandria Real Estate Equities, Inc., Fred Hutch has a new, state-of-the-art learning laboratory where high school and college students who participate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results